글루코사민 시장(2026-2030년)

The global glucosamine market is forecasted to grow by USD 356.5 mn during 2025-2030, accelerating at a CAGR of 6.7% during the forecast period. The report on the global glucosamine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of osteoarthritis and aging demographic structures, expansion of preventive healthcare and nutritional supplements, rise of plant-based innovations and clean-label sourcing.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global glucosamine market is segmented as below:

By Application

• Nutritional supplements
• Food and beverages
• Dairy products

By Product Type

• Glucosamine sulfate
• Glucosamine hydrochloride
• N-Acetyl glucosamine
• Others

By Source

• Marine-derived
• Fermentation-derived

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
• South America
  • Brazil
  • Argentina
  • Chile
• Middle East and Africa
  • UAE
  • South Africa
  • Turkey
• Rest of World (ROW)

This study identifies the proliferation of multi-ingredient synergy and advanced delivery formats as one of the prime reasons driving the global glucosamine market growth during the next few years. Also, expansion of veterinary nutraceutical and pet humanization sector and digital retail penetration and personalized nutrition platforms will lead to sizable demand in the market.

The report on the global glucosamine market covers the following areas:

• Global glucosamine market sizing
• Global glucosamine market forecast
• Global glucosamine market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global glucosamine market vendors that include Ampil, Beloorbayir Biotech Ltd., Bioiberica S.A.U., CAPTEK Softgel International Inc., Chemball HangZhou Chemicals, Chibio Biotech, Ethical Naturals Inc., Foodchem International Corp., FR Biotech, GNC Holdings LLC, Golden Shell Pharmaceutical, Neithal Biotech Pvt. Ltd., NOW Health Group Inc., Nutramax Laboratories Inc., Prakruti Products Pvt. Ltd., Shuanglin Bio Technology Co. Ltd., Sigma Aldrich Chemicals Ltd., Sinochem Nanjing, Swanson Health Products Inc., The Himalayan Organics, Yaizu Suisankagaku Industry. Also, the global glucosamine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by Product Type
  • Executive Summary - Chart on Market Segmentation by Source
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Glucosamine Market 2020 - 2024
  • Historic Market Size - Data Table on Global Glucosamine Market 2020 - 2024 ($ million)
• 5.2 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.3 Product Type segment analysis 2020 - 2024
  • Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
• 5.4 Source segment analysis 2020 - 2024
  • Historic Market Size - Source Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global glucosamine market
• 6.2 Impact of geopolitical conflicts on global glucosamine market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Application

• 8.1 Market segments
• 8.2 Comparison by Application
• 8.3 Nutritional supplements - Market size and forecast 2025-2030
• 8.4 Food and beverages - Market size and forecast 2025-2030
• 8.5 Dairy products - Market size and forecast 2025-2030
• 8.6 Market opportunity by Application
  • Market opportunity by Application ($ million)

9 Market Segmentation by Product Type

• 9.1 Market segments
• 9.2 Comparison by Product Type
• 9.3 Glucosamine sulfate - Market size and forecast 2025-2030
• 9.4 Glucosamine hydrochloride - Market size and forecast 2025-2030
• 9.5 N-Acetyl glucosamine - Market size and forecast 2025-2030
• 9.6 Others - Market size and forecast 2025-2030
• 9.7 Market opportunity by Product Type
  • Market opportunity by Product Type ($ million)

10 Market Segmentation by Source

• 10.1 Market segments
• 10.2 Comparison by Source
• 10.3 Marine-derived - Market size and forecast 2025-2030
• 10.4 Fermentation-derived - Market size and forecast 2025-2030
• 10.5 Market opportunity by Source
  • Market opportunity by Source ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 APAC - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Australia - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 South America - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Argentina - Market size and forecast 2025-2030
  • 12.6.3 Chile - Market size and forecast 2025-2030
• 12.7 Middle East and Africa - Market size and forecast 2025-2030
  • 12.7.1 Saudi Arabia - Market size and forecast 2025-2030
  • 12.7.2 UAE - Market size and forecast 2025-2030
  • 12.7.3 South Africa - Market size and forecast 2025-2030
  • 12.7.4 Israel - Market size and forecast 2025-2030
  • 12.7.5 Turkey - Market size and forecast 2025-2030
• 12.8 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising prevalence of osteoarthritis and aging demographic structures
  • Expansion of preventive healthcare and nutritional supplements
  • Rise of plant-based innovations and clean-label sourcing
• 13.2 Market challenges
  • Regulatory scrutiny and inconsistent clinical perception
  • Raw material sourcing vulnerabilities and supply chain pressures
  • Intense industry commoditization and pricing compression
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Proliferation of multi-ingredient synergy and advanced delivery formats
  • Expansion of veterinary nutraceutical and pet humanization sector
  • Digital retail penetration and personalized nutrition platforms

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Ampil
  • Ampil - Overview
  • Ampil - Product / Service
  • Ampil - Key offerings
  • SWOT
• 15.5 Beloorbayir Biotech Ltd.
  • Beloorbayir Biotech Ltd. - Overview
  • Beloorbayir Biotech Ltd. - Product / Service
  • Beloorbayir Biotech Ltd. - Key offerings
  • SWOT
• 15.6 Bioiberica S.A.U.
  • Bioiberica S.A.U. - Overview
  • Bioiberica S.A.U. - Product / Service
  • Bioiberica S.A.U. - Key offerings
  • SWOT
• 15.7 FR Biotech
  • FR Biotech - Overview
  • FR Biotech - Product / Service
  • FR Biotech - Key offerings
  • SWOT
• 15.8 GNC Holdings LLC
  • GNC Holdings LLC - Overview
  • GNC Holdings LLC - Product / Service
  • GNC Holdings LLC - Key offerings
  • SWOT
• 15.9 Golden Shell Pharmaceutical
  • Golden Shell Pharmaceutical - Overview
  • Golden Shell Pharmaceutical - Product / Service
  • Golden Shell Pharmaceutical - Key offerings
  • SWOT
• 15.10 Neithal Biotech Pvt. Ltd.
  • Neithal Biotech Pvt. Ltd. - Overview
  • Neithal Biotech Pvt. Ltd. - Product / Service
  • Neithal Biotech Pvt. Ltd. - Key offerings
  • SWOT
• 15.11 NOW Health Group Inc.
  • NOW Health Group Inc. - Overview
  • NOW Health Group Inc. - Product / Service
  • NOW Health Group Inc. - Key offerings
  • SWOT
• 15.12 Nutramax Laboratories Inc.
  • Nutramax Laboratories Inc. - Overview
  • Nutramax Laboratories Inc. - Product / Service
  • Nutramax Laboratories Inc. - Key offerings
  • SWOT
• 15.13 Prakruti Products Pvt. Ltd.
  • Prakruti Products Pvt. Ltd. - Overview
  • Prakruti Products Pvt. Ltd. - Product / Service
  • Prakruti Products Pvt. Ltd. - Key offerings
  • SWOT
• 15.14 Sigma Aldrich Chemicals Ltd.
  • Sigma Aldrich Chemicals Ltd. - Overview
  • Sigma Aldrich Chemicals Ltd. - Product / Service
  • Sigma Aldrich Chemicals Ltd. - Key offerings
  • SWOT
• 15.15 Sinochem Nanjing
  • Sinochem Nanjing - Overview
  • Sinochem Nanjing - Product / Service
  • Sinochem Nanjing - Key offerings
  • SWOT
• 15.16 Swanson Health Products Inc.
  • Swanson Health Products Inc. - Overview
  • Swanson Health Products Inc. - Product / Service
  • Swanson Health Products Inc. - Key offerings
  • SWOT
• 15.17 The Himalayan Organics
  • The Himalayan Organics - Overview
  • The Himalayan Organics - Product / Service
  • The Himalayan Organics - Key offerings
  • SWOT
• 15.18 Yaizu Suisankagaku Industry
  • Yaizu Suisankagaku Industry - Overview
  • Yaizu Suisankagaku Industry - Product / Service
  • Yaizu Suisankagaku Industry - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations